Skip to main content
Premium Trial:

Request an Annual Quote

OraSure Technologies: Scott Gleason

OraSure Technologies has appointed Scott Gleason as senior vice president of investor relations and corporate communications. Gleason previously served as SVP of investor relations and corporate strategy for Myriad Genetics. Prior to that, he was a senior publishing analyst at Stephens from 2005 to 2013, covering the life science tools and diagnostics industry. Gleason also was a US Air Force aircraft maintenance officer and participated in two wartime deployments.

The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.